Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail

The Hallmarks of Severe Pulmonary Arterial Hypertension: The Cancer Hypothesis - Ten years later

(2020) Carlyne D Cool et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous

(2019) Frédéric Perros et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension

(2019) Nils P Nickel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

(2018) Luca Falzone et al.   Frontiers in Pharmacology

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

(2016) Christophe Guignabert et al.   JOURNAL OF CLINICAL INVESTIGATION

Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

(2013) Marius M. Hoeper et al.   CIRCULATION

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The Cancer Paradigm of Severe Pulmonary Arterial Hypertension

(2008) Pradeep R. Rai et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE